Development of [ 225 Ac]Ac-DOTA-C595 as radioimmunotherapy of pancreatic cancer: in vitro evaluation, dosimetric assessment and detector calibration.
Ashleigh HullWilliam HsiehArtem BorysenkoWilliam TieuDylan BartholomeuszEva BezakPublished in: EJNMMI radiopharmacy and chemistry (2023)
Ac]Ac-DOTA-C595 was shown to target and induce a therapeutic effect in MUC1-CE expressing PDAC cells.